We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,307
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTVA
7451
MetaVia Inc
MTVA
$7.69M
0
EGF
7452
DELISTED
Blackrock Enhanced Government Fund, Inc.
EGF
$7K ﹤0.01%
515
YTEN
7453
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$7K ﹤0.01%
+43
New +$13.7K
MOTS
7454
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$7K ﹤0.01%
10
-42
-81% -$23.7K
ISDX
7455
DELISTED
Invesco Exchange-Traded Self-Indexed Fund Trust Invesco RAFI Strategic Developed ex-US ETF
ISDX
$7K ﹤0.01%
+280
New +$7.11K
ALR
7456
DELISTED
AlerisLife Inc
ALR
$7K ﹤0.01%
1,893
+1,637
+639% +$7.87K
VIVE
7457
DELISTED
VIVEVE MED INC
VIVE
$7K ﹤0.01%
604
+584
+2,920% +$16.6K
ICOL
7458
DELISTED
iShares MSCI Colombia ETF
ICOL
$7K ﹤0.01%
+538
New +$7.06K
FNGZ
7459
DELISTED
MicroSectors FANG+ Index -2X Inverse Leveraged ETNs due January 8, 2038
FNGZ
$7K ﹤0.01%
245
JMP
7460
DELISTED
JMP Group LLC
JMP
$7K ﹤0.01%
2,013
-2,477
-55% -$8.05K
LACQ
7461
DELISTED
Leisure Acquisition Corp.
LACQ
$7K ﹤0.01%
629
-1,600
-72% -$16.5K
DL
7462
DELISTED
China Distance Education Holdings Limited
DL
$7K ﹤0.01%
+887
New +$6.28K
BMLP
7463
DELISTED
Dorsey Wright MLP Index ETNs due December 10, 2036
BMLP
$7K ﹤0.01%
152
+138
+986% +$6.2K
MCEP
7464
DELISTED
Mid-Con Energy Partners, LP
MCEP
$7K ﹤0.01%
1,250
+473
+61% +$2.99K
FHK
7465
DELISTED
First Trust Hong Kong AlphaDEX Fund
FHK
$7K ﹤0.01%
193
-24
-11% -$800
GRSHU
7466
DELISTED
Gores Holdings III, Inc. Units
GRSHU
$7K ﹤0.01%
606
ESTR
7467
DELISTED
Estre Ambiental, Inc.
ESTR
$7K ﹤0.01%
17,396
+14,896
+596% +$4.12K
RHE
7468
DELISTED
Regional Health Properties, Inc.
RHE
$7K ﹤0.01%
5,107
-1,260
-20% -$1.79K
EMMS
7469
DELISTED
Emmis Communications Corp
EMMS
$7K ﹤0.01%
1,760
-1,825
-51% -$7.78K
FLRU
7470
DELISTED
Franklin FTSE Russia ETF
FLRU
$7K ﹤0.01%
238
+219
+1,153% +$6.22K
ALT icon
7471
Altimmune
ALT
$589M
$6K ﹤0.01%
3,131
+2,700
+626% +$4.99K
AMOM icon
7472
Qraft AI-Enhanced US Large Cap Momentum ETF
AMOM
$24.6M
$6K ﹤0.01%
243
ARCT icon
7473
Arcturus Therapeutics
ARCT
$178M
$6K ﹤0.01%
+557
New +$5.83K
ASRV icon
7474
AmeriServ Financial
ASRV
$78.4M
$6K ﹤0.01%
1,517
+52
+4% +$217
FABC
7475
Fabric.AI Inc
FABC
$18.2M
$6K ﹤0.01%
10
+2
+25% +$849

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,307 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.